Acurx Pharmaceuticals, Inc.股价重挫20.42% 市值跌12.59万美元

市场透视2025-07-30

北京时间2025年07月30日22时52分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅跳水20.42%。截至发稿，该股报0.300美元/股，成交量27.4767万股，换手率0.93%，振幅4.59%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.15百万美元，每股收益-0.11美元，毛利0.00美元，市盈率-0.53倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555028686?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-30 22:52","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2555028686","market":"us","top_or_hot":-1,"title":"Acurx Pharmaceuticals, Inc.股价重挫20.42% 市值跌12.59万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年07月30日22时52分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅跳水20.42%。截至发稿，该股报0.300美元/股，成交量27.4767万股，换手率0.93%，振幅4.59%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.15百万美元，每股收益-0.11美元，毛利0.00美元，市盈率-0.53倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225204a46bcfbd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Acurx Pharmaceuticals, Inc.股价重挫20.42% 市值跌12.59万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAcurx Pharmaceuticals, Inc.股价重挫20.42% 市值跌12.59万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-30 22:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225204a46bcfbd&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年07月30日22时52分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅跳水20.42%。截至发稿，该股报0.300美元/股，成交量27.4767万股，换手率0.93%，振幅4.59%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.15百万美元，每股收益-0.11美元，毛利0.00美元，市盈率-0.53倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225204a46bcfbd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225204a46bcfbd&s=b","article_id":"2555028686","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225204a46bcfbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555028686","pubTimestamp":1753887124,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年07月30日22时52分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水20.42%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","BK4563":"昨日强势股","BK4139":"生物科技","ACXP":"Acurx Pharmaceuticals, LLC*"},"translate_title":"Acurx Pharmaceuticals, Inc. Stock Plunges 20.42%, Market Value Falls $125,900","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACXP":0.9},"content_text":"北京时间2025年07月30日22时52分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅跳水20.42%。截至发稿，该股报0.300美元/股，成交量27.4767万股，换手率0.93%，振幅4.59%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.15百万美元，每股收益-0.11美元，毛利0.00美元，市盈率-0.53倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Replimune Group, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 (To Pur Com)、Pasithea Therapeutics Corp C/Wts 12/08/2026 (To Pur Com)涨幅较大，Tnf Pharmaceuticals, Inc.、Replimune Group, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为301.49%、139.68%、138.75%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 (To Pur Com)、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 (To Pur Com)、Replimune Group, Inc.，振幅分别为53.86%、47.44%、40.93%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。该公司的方法是开发具有革兰氏阳性选择性谱的候选抗生素。该公司的部门包括开发临床和临床前候选产品，以开发公司的专有新疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555028686","isCrawlerRequest":true}